@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP296592.RAPoY0gDAMhNdQLnfRSJDj34BzMnV7XVFd-TCYif6Z6PU130_head { this: np:hasAssertion dgn-np:NP296592.RAPoY0gDAMhNdQLnfRSJDj34BzMnV7XVFd-TCYif6Z6PU130_assertion; np:hasProvenance dgn-np:NP296592.RAPoY0gDAMhNdQLnfRSJDj34BzMnV7XVFd-TCYif6Z6PU130_provenance; np:hasPublicationInfo dgn-np:NP296592.RAPoY0gDAMhNdQLnfRSJDj34BzMnV7XVFd-TCYif6Z6PU130_publicationInfo; a np:Nanopublication . dgn-np:NP296592.RAPoY0gDAMhNdQLnfRSJDj34BzMnV7XVFd-TCYif6Z6PU130_assertion a np:Assertion . dgn-np:NP296592.RAPoY0gDAMhNdQLnfRSJDj34BzMnV7XVFd-TCYif6Z6PU130_provenance a np:Provenance . dgn-np:NP296592.RAPoY0gDAMhNdQLnfRSJDj34BzMnV7XVFd-TCYif6Z6PU130_publicationInfo a np:PublicationInfo . } dgn-np:NP296592.RAPoY0gDAMhNdQLnfRSJDj34BzMnV7XVFd-TCYif6Z6PU130_assertion { miriam-gene:50652 a ncit:C16612 . lld:C0376358 a ncit:C7057 . dgn-gda:DGNe94a93a81dbdcc5d527bb93f64531957 sio:SIO_000628 miriam-gene:50652, lld:C0376358; a sio:SIO_001121 . } dgn-np:NP296592.RAPoY0gDAMhNdQLnfRSJDj34BzMnV7XVFd-TCYif6Z6PU130_provenance { dgn-np:NP296592.RAPoY0gDAMhNdQLnfRSJDj34BzMnV7XVFd-TCYif6Z6PU130_assertion dcterms:description "[Moreover, the PCA3 score was significantly higher in men with high-grade prostate intraepithelial neoplasia (HGPIN) versus those without HGPIN, clinical stage T2 versus T1, Gleason score >or=7 versus <7, and `significant` versus `indolent` (clinical stage T1c, PSA density [PSAD] <0.15ng/ml, Gleason score in biopsy ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }